PCP2
gene geneOn this page
Also known as MGC41903GPSM4
Summary
PCP2 (Purkinje cell protein 2, HGNC:30209) is a protein-coding gene on chromosome 19p13.2, encoding Purkinje cell protein 2 homolog (Q8IVA1). May function as a cell-type specific modulator for G protein-mediated cell signaling.
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to act upstream of or within G protein-coupled opsin signaling pathway. Predicted to be located in neuronal cell body.
Source: NCBI Gene 126006 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 45 total — 1 pathogenic
- MANE Select transcript:
NM_174895
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30209 |
| Approved symbol | PCP2 |
| Name | Purkinje cell protein 2 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC41903, GPSM4 |
| Ensembl gene | ENSG00000174788 |
| Ensembl biotype | protein_coding |
| OMIM | 619344 |
| Entrez | 126006 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000311069, ENST00000598935
RefSeq mRNA: 2 — MANE Select: NM_174895
NM_001271830, NM_174895
CCDS: CCDS32893, CCDS62521
Canonical transcript exons
ENST00000311069 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001202217 | 7632716 | 7632830 |
| ENSE00001202233 | 7632393 | 7632517 |
| ENSE00001241372 | 7633407 | 7633719 |
| ENSE00003065498 | 7631615 | 7631808 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 96.38.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7272 / max 352.0418, expressed in 22 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178854 | 0.3806 | 11 |
| 178856 | 0.1526 | 3 |
| 178855 | 0.1301 | 4 |
| 178857 | 0.0490 | 3 |
| 178853 | 0.0150 | 3 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.38 | gold quality |
| right testis | UBERON:0004534 | 96.01 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.19 | gold quality |
| testis | UBERON:0000473 | 92.96 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.96 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.87 | gold quality |
| cerebellum | UBERON:0002037 | 92.53 | gold quality |
| cerebellar vermis | UBERON:0004720 | 86.64 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.70 | gold quality |
| right uterine tube | UBERON:0001302 | 81.78 | gold quality |
| sperm | CL:0000019 | 80.77 | silver quality |
| granulocyte | CL:0000094 | 80.70 | gold quality |
| monocyte | CL:0000576 | 77.30 | gold quality |
| leukocyte | CL:0000738 | 76.75 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.23 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 75.97 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.78 | gold quality |
| adult organism | UBERON:0007023 | 74.77 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 74.61 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 74.58 | gold quality |
| body of pancreas | UBERON:0001150 | 74.49 | gold quality |
| skin of abdomen | UBERON:0001416 | 74.37 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.32 | gold quality |
| minor salivary gland | UBERON:0001830 | 74.22 | gold quality |
| parotid gland | UBERON:0001831 | 73.79 | gold quality |
| thyroid gland | UBERON:0002046 | 73.73 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 72.82 | gold quality |
| skin of leg | UBERON:0001511 | 72.31 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 71.95 | gold quality |
| cortex of kidney | UBERON:0001225 | 71.57 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 12484.03 |
| E-GEOD-137537 | yes | 4072.95 |
| E-MTAB-11121 | yes | 4030.61 |
| E-GEOD-134144 | yes | 31.96 |
| E-ANND-3 | no | 1.23 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): JUN, NR2F1, POU1F1, RARA, RORA, RXRA, RXRB, THRA
Literature-anchored findings (GeneRIF, showing 2)
- The data demonstrate that PCP-2 is a comparatively weak GoLoco motif protein that exhibits highest affinity interactions and GDI activity toward Galphai1, Galphai2, and Galphai3 subunits. (PMID:16298104)
- characterization of the mouse 136 aa conserved isoform, Ret-PCP2 (PMID:18768681)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pcp2 | ENSMUSG00000004630 |
| rattus_norvegicus | Pcp2 | ENSRNOG00000000993 |
Protein
Protein identifiers
Purkinje cell protein 2 homolog — Q8IVA1 (reviewed: Q8IVA1)
All UniProt accessions (1): Q8IVA1
UniProt curated annotations — full annotation on UniProt →
Function. May function as a cell-type specific modulator for G protein-mediated cell signaling.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IVA1-1 | 1 | yes |
| Q8IVA1-2 | 2 |
RefSeq proteins (2): NP_001258759, NP_777555* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003109 | GoLoco_motif | Conserved_site |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR042168 | Pcp2 | Family |
Pfam: PF02188
UniProt features (9 total): domain 2, region of interest 2, compositionally biased region 2, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IVA1-F1 | 70.65 | 0.17 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 127
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
MSigDB gene sets: 48 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_PHOTOTRANSDUCTION, GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_RADIATION, GOBP_RESPONSE_TO_LIGHT_STIMULUS, LEE_TARGETS_OF_PTCH1_AND_SUFU_DN, GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS, LEIN_CEREBELLUM_MARKERS, GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, chr19p13
GO Biological Process (1): G protein-coupled opsin signaling pathway (GO:0016056)
GO Molecular Function (3): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515), GTPase regulator activity (GO:0030695)
GO Cellular Component (0):
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor signaling pathway | 1 |
| phototransduction | 1 |
| phototransduction, visible light | 1 |
| cellular response to light stimulus | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| GTPase activity | 1 |
| nucleoside-triphosphatase regulator activity | 1 |
Protein interactions and networks
STRING
906 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PCP2 | RIC8A | Q9NPQ8 | 639 |
| PCP2 | RIC8B | Q9NVN3 | 581 |
| PCP2 | GPSM3 | Q9Y4H4 | 570 |
| PCP2 | PET100 | P0DJ07 | 542 |
| PCP2 | CBLN1 | P02682 | 541 |
| PCP2 | GABRA6 | Q16445 | 532 |
| PCP2 | RGS14 | O43566 | 504 |
| PCP2 | RAP1GAP | P47736 | 477 |
| PCP2 | RGS12 | O14924 | 474 |
| PCP2 | CABP5 | Q9NP86 | 468 |
| PCP2 | CREG2 | Q8IUH2 | 462 |
| PCP2 | GNAO1 | P09471 | 457 |
| PCP2 | MCEMP1 | Q8IX19 | 442 |
| PCP2 | CALB1 | P05937 | 435 |
| PCP2 | ATXN1L | P0C7T5 | 434 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PCP2 | GNAI3 | psi-mi:“MI:0915”(physical association) | 0.680 |
| GNAI3 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.680 |
| SPANXN3 | SUOX | psi-mi:“MI:0914”(association) | 0.640 |
| MEOX1 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GNAI1 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GNAI2 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM38A | DOK2 | psi-mi:“MI:0914”(association) | 0.530 |
| CST9 | ITGA4 | psi-mi:“MI:0914”(association) | 0.530 |
| RNASE2 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CENPM | DOK2 | psi-mi:“MI:0914”(association) | 0.350 |
| HSD17B3 | POTEI | psi-mi:“MI:0914”(association) | 0.350 |
| VPS28 | DCAF6 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS28 | PRPF6 | psi-mi:“MI:0914”(association) | 0.350 |
| PCP2 | MEOX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PCP2 | GNAI3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GNAI1 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PCP2 | GNAI2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GNAI3 | PCP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PCP2 | GNAI1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): PCP2 (Affinity Capture-MS), GNAI3 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS), GNAI3 (Affinity Capture-MS), PCP2 (Two-hybrid), PCP2 (Two-hybrid), PCP2 (Two-hybrid), PCP2 (Two-hybrid), PCP2 (Affinity Capture-MS), PCP2 (Affinity Capture-MS)
ESM2 similar proteins: A2AIP0, A2RRU4, A2RRW4, A4Q9F4, A6QM06, A6QNS9, A6QPC0, A8MTA8, E1BBQ2, F1LQY6, G3X6E2, H3BNL1, O70373, P29590, P50747, P55199, P97260, Q04841, Q12770, Q2TBR5, Q4QR77, Q5E9N3, Q5MNU5, Q5RDC3, Q69Z89, Q6GQT6, Q6J272, Q702N8, Q70EL4, Q7Z4S9, Q8BL74, Q8BUM9, Q8C419, Q8IVA1, Q8IW40, Q8N1F8, Q8N9H8, Q8WUA4, Q91ZP9, Q920N2
Diamond homologs: P12660, Q8IVA1
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| RORA | “up-regulates quantity by expression” | PCP2 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 4 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3248484 | NC_000019.9:g.(?7694720)(7712696_?)del | Pathogenic |
SpliceAI
661 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:7632388:CCTA:C | donor_loss | 1.0000 |
| 19:7632389:CTAC:C | donor_loss | 1.0000 |
| 19:7632390:TA:T | donor_loss | 1.0000 |
| 19:7632391:ACCTT:A | donor_loss | 1.0000 |
| 19:7632392:CCTT:C | donor_loss | 1.0000 |
| 19:7632514:CTCT:C | acceptor_gain | 1.0000 |
| 19:7632516:CT:C | acceptor_gain | 1.0000 |
| 19:7632518:C:CC | acceptor_gain | 1.0000 |
| 19:7632538:T:C | acceptor_gain | 1.0000 |
| 19:7632714:A:AC | donor_gain | 1.0000 |
| 19:7632715:C:CC | donor_gain | 1.0000 |
| 19:7632715:CGG:C | donor_gain | 1.0000 |
| 19:7632715:CGGCT:C | donor_gain | 1.0000 |
| 19:7632826:CCCGC:C | acceptor_gain | 1.0000 |
| 19:7632827:CCGC:C | acceptor_gain | 1.0000 |
| 19:7632827:CCGCC:C | acceptor_gain | 1.0000 |
| 19:7632828:CGC:C | acceptor_gain | 1.0000 |
| 19:7632828:CGCC:C | acceptor_gain | 1.0000 |
| 19:7631807:TCCT:T | acceptor_loss | 0.9900 |
| 19:7632391:A:AC | donor_gain | 0.9900 |
| 19:7632392:C:CC | donor_gain | 0.9900 |
| 19:7632516:CTCTG:C | acceptor_loss | 0.9900 |
| 19:7632517:TC:T | acceptor_loss | 0.9900 |
| 19:7632519:T:A | acceptor_loss | 0.9900 |
| 19:7632537:C:CC | acceptor_gain | 0.9900 |
| 19:7632538:T:TC | acceptor_gain | 0.9900 |
| 19:7632714:ACGG:A | donor_gain | 0.9900 |
| 19:7632715:CG:C | donor_gain | 0.9900 |
| 19:7632715:CGGC:C | donor_gain | 0.9900 |
| 19:7632829:GC:G | acceptor_gain | 0.9900 |
AlphaMissense
895 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:7632440:G:T | R82S | 0.986 |
| 19:7632439:C:G | R82P | 0.984 |
| 19:7632441:T:A | Q81H | 0.984 |
| 19:7632441:T:G | Q81H | 0.984 |
| 19:7632796:A:G | L29P | 0.984 |
| 19:7632455:G:T | R77S | 0.983 |
| 19:7632454:C:G | R77P | 0.978 |
| 19:7632793:A:G | L30P | 0.976 |
| 19:7632451:A:G | M78T | 0.974 |
| 19:7632805:A:G | F26S | 0.973 |
| 19:7632412:A:G | F91S | 0.968 |
| 19:7632475:A:G | L70P | 0.964 |
| 19:7632475:A:T | L70Q | 0.963 |
| 19:7632487:A:G | L66P | 0.963 |
| 19:7632804:G:C | F26L | 0.962 |
| 19:7632804:G:T | F26L | 0.962 |
| 19:7632806:A:G | F26L | 0.962 |
| 19:7632448:T:A | D79V | 0.961 |
| 19:7632451:A:C | M78R | 0.961 |
| 19:7632462:C:A | Q74H | 0.960 |
| 19:7632462:C:G | Q74H | 0.960 |
| 19:7632473:C:G | A71P | 0.960 |
| 19:7632442:T:G | Q81P | 0.959 |
| 19:7632449:C:G | D79H | 0.958 |
| 19:7632451:A:T | M78K | 0.957 |
| 19:7632475:A:C | L70R | 0.957 |
| 19:7632411:G:C | F91L | 0.953 |
| 19:7632411:G:T | F91L | 0.953 |
| 19:7632413:A:G | F91L | 0.953 |
| 19:7632455:G:C | R77G | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000395037 (19:7637121 G>A), RS1000662251 (19:7637012 G>C), RS1000815194 (19:7637729 G>A), RS1000859301 (19:7637435 C>A,T), RS1001818407 (19:7638784 G>A), RS1001946530 (19:7638124 T>C), RS1002117633 (19:7633644 G>A), RS1002717016 (19:7634702 C>T), RS1002723883 (19:7635688 C>A), RS1002868048 (19:7631300 C>A,G,T), RS1003329572 (19:7631437 C>A,G,T), RS1003505006 (19:7631494 A>C,G), RS1003557616 (19:7631233 C>T), RS1004114131 (19:7635813 G>C), RS1006108737 (19:7637760 G>A,T)
Disease associations
OMIM: gene MIM:619344 | disease phenotypes: MIM:613101
GenCC curated gene-disease
Mondo (1): familial hemophagocytic lymphohistiocytosis 5 (MONDO:0013135)
Orphanet (1): Familial hemophagocytic lymphohistiocytosis (Orphanet:540)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005934_2 | Neuropathic pain in head and neck cancer | 3.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005762 | neuropathic pain |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567752 | Hemophagocytic Lymphohistiocytosis, Familial, 5 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| di-n-butylphosphoric acid | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): familial hemophagocytic lymphohistiocytosis 5